Raymond James & Associates’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-33,270
Closed -$659K 3821
2022
Q2
$659K Sell
33,270
-29,319
-47% -$581K ﹤0.01% 2722
2022
Q1
$1.98M Buy
+62,589
New +$1.98M ﹤0.01% 2138
2021
Q3
Sell
-11,206
Closed -$436K 3955
2021
Q2
$436K Buy
11,206
+1,044
+10% +$40.6K ﹤0.01% 3175
2021
Q1
$293K Buy
+10,162
New +$293K ﹤0.01% 3345
2020
Q3
Sell
-12,462
Closed -$253K 3475
2020
Q2
$253K Sell
12,462
-27,688
-69% -$562K ﹤0.01% 2994
2020
Q1
$415K Sell
40,150
-62,062
-61% -$641K ﹤0.01% 2539
2019
Q4
$3.85M Sell
102,212
-20,261
-17% -$763K ﹤0.01% 1416
2019
Q3
$5.71M Sell
122,473
-4,837
-4% -$226K 0.01% 1144
2019
Q2
$6.66M Buy
127,310
+4,884
+4% +$255K 0.01% 1077
2019
Q1
$8.44M Buy
122,426
+13,703
+13% +$945K 0.01% 898
2018
Q4
$6.48M Sell
108,723
-57,994
-35% -$3.46M 0.01% 972
2018
Q3
$19.3M Buy
166,717
+19,971
+14% +$2.31M 0.03% 538
2018
Q2
$18.5M Buy
146,746
+15,915
+12% +$2.01M 0.03% 533
2018
Q1
$14.2M Buy
130,831
+27,759
+27% +$3M 0.03% 604
2017
Q4
$11.3M Sell
103,072
-469
-0.5% -$51.4K 0.02% 710
2017
Q3
$10.2M Sell
103,541
-1,613
-2% -$159K 0.02% 719
2017
Q2
$10.6M Buy
105,154
+19,423
+23% +$1.97M 0.02% 673
2017
Q1
$9.9M Buy
85,731
+4,549
+6% +$526K 0.02% 677
2016
Q4
$9.75M Sell
81,182
-13,527
-14% -$1.62M 0.02% 642
2016
Q3
$10.6M Buy
94,709
+21,637
+30% +$2.43M 0.03% 573
2016
Q2
$9.05M Buy
73,072
+2,766
+4% +$343K 0.03% 575
2016
Q1
$7.9M Sell
70,306
-12,170
-15% -$1.37M 0.03% 605
2015
Q4
$8.97M Buy
82,476
+63,369
+332% +$6.89M 0.03% 556
2015
Q3
$1.91M Buy
19,107
+1,929
+11% +$193K 0.01% 1245
2015
Q2
$1.96M Buy
17,178
+3,805
+28% +$434K 0.01% 1330
2015
Q1
$1.4M Buy
+13,373
New +$1.4M 0.01% 1464